Molina Healthcare (MOH) Projected to Release Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is anticipated to release its Q2 2026 results after the market closes on Wednesday, July 22nd. Analysts expect Molina Healthcare to post earnings of $1.37 per share and revenue of $10.8320 billion for the quarter. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Parties may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, July 23, 2026 at 8:00 AM ET.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter in the prior year, the business posted $6.08 earnings per share. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. On average, analysts expect Molina Healthcare to post $5 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Molina Healthcare Price Performance

Molina Healthcare stock opened at $229.65 on Tuesday. The stock’s fifty day moving average price is $204.33 and its two-hundred day moving average price is $176.00. Molina Healthcare has a one year low of $121.06 and a one year high of $244.89. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. The firm has a market cap of $11.96 billion, a PE ratio of 67.94 and a beta of 0.74.

Analyst Upgrades and Downgrades

MOH has been the topic of several analyst reports. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a report on Wednesday, April 29th. Jefferies Financial Group set a $230.00 price target on Molina Healthcare in a research note on Tuesday, July 14th. Barclays dropped their price target on Molina Healthcare from $199.00 to $184.00 and set an “underweight” rating for the company in a research note on Wednesday, July 8th. Morgan Stanley upped their price objective on shares of Molina Healthcare from $146.00 to $167.00 and gave the stock an “equal weight” rating in a research report on Thursday, June 4th. Finally, TD Cowen increased their price objective on shares of Molina Healthcare from $163.00 to $230.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Three equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $207.06.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares in the company, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by corporate insiders.

Institutional Trading of Molina Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the business. Quarry LP acquired a new position in Molina Healthcare during the fourth quarter worth about $32,000. Triumph Capital Management boosted its stake in shares of Molina Healthcare by 4,625.0% in the 4th quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after purchasing an additional 185 shares in the last quarter. Brown Brothers Harriman & Co. boosted its stake in shares of Molina Healthcare by 96.1% in the 4th quarter. Brown Brothers Harriman & Co. now owns 249 shares of the company’s stock valued at $43,000 after purchasing an additional 122 shares in the last quarter. MUFG Securities EMEA plc bought a new stake in shares of Molina Healthcare during the 2nd quarter valued at approximately $48,000. Finally, DV Equities LLC bought a new stake in shares of Molina Healthcare during the 4th quarter valued at approximately $76,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.